ADAR1 Capital Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.7M Buy
632,556
+92,390
+17% +$5.87M 2.51% 7
2025
Q4
$34.3M Buy
540,166
+21,245
+4% +$1.32M 2.57% 8
2025
Q3
$28.5M Sell
518,921
-63,226
-11% -$2.6M 2.82% 11
2025
Q2
$19.2M Buy
582,147
+191,418
+49% +$6.66M 3.12% 9
2025
Q1
$15.7M Sell
390,729
-23,480
-6% -$1.08M 3.02% 6
2024
Q4
$19.5M Sell
414,209
-496,973
-55% -$25.8M 4.02% 6
2024
Q3
$48.1M Buy
911,182
+57,320
+7% +$3.19M 8.06% 1
2024
Q2
$46.3M Buy
853,862
+534,352
+167% +$32.3M 9.32% 2
2024
Q1
$22.4M Buy
319,510
+227,428
+247% +$17.6M 6.12% 7
2023
Q4
$7.69M Buy
+92,082
New +$3.33M 3.44% 6

Other funds holding CYTK